City of Hope

This is your central portal for breaking news, the latest research and important updates from City of Hope. Bookmark this page and check back often for updates.

Meeting News

Atezolizumab-bevacizumab combination extends PFS in PD-L1-positive metastatic renal cell carcinoma

November 6, 2017
MIAMI — The combination of atezolizumab and bevacizumab demonstrated encouraging activity as first-line treatment for PD-L1-positive metastatic…
Meeting NewsVideo

VIDEO: Symposium offers research, mentorship opportunities

November 3, 2017
MIAMI Toni K. Choueiri, MD, from Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, interviews two members of the Scientific…

City of Hope names director of pharmaceutical initiatives

October 21, 2017
George Somlo, M D, has been appointed director of pharmaceutical initiatives at City of Hope. Somlo, recognized for his research…

City of Hope announces two faculty appointments

September 6, 2017
City of Hope announced the appointment of two faculty members. Rick Kittles, PhD, will serve professor and founding director of the division…
Cover Story

Success of abiraterone trials prompts ‘mind shift’ in prostate cancer treatment

HemOnc Today, September 10, 2017
Abiraterone acetate is poised to challenge docetaxel as the standard addition to androgen deprivation therapy for treatment of newly diagnosed…
In the Journals Plus

Older patients with cancer may burden caregivers by overestimating physical abilities

August 14, 2017
Older patients with cancer often reported having better physical function, mental health and social support than their caregivers’ assessments…
In the Journals Plus

Anal cancer survivors have increased risk for HPV–related second cancers

July 6, 2017
Survivors of index squamous cell carcinoma of the anus faced an increased risk for subsequent HPV–related cancers, according to a cohort study…

Indo-American Cancer Association honors City of Hope researcher

June 14, 2017
The Indo-American Cancer Association honored Ravi Salgia, MD, PhD, with its IACA Award for Outstanding Contributions to Oncology. Salgia, who serves…
Cover Story

Identification of prognostic markers remains ‘holy grail’ in follicular lymphoma research

HemOnc Today, May 10, 2017
Approximately 2% of Americans will be diagnosed with non-Hodgkin lymphoma during their lifetimes, according to NCI statistics. Follicular lymphoma…
Meeting NewsPerspective

Circulating tumor cell test can detect lung cancer recurrence before CT

March 21, 2017
Blood tests that used circulating tumor cells as biomarkers detected recurrences of locally advanced non–small cell lung cancer months earlier…

City of Hope names provost for clinical faculty

March 18, 2017
Arti Hurria , MD, has been named provost for clinical faculty at City of Hope. Hurria, a HemOnc Today Editorial Board member, will…
Meeting News

Use of antibiotics could reduce efficacy of immunotherapy

February 14, 2017
Cancer worsened more quickly in patients who received antibiotics less than 1 month before starting immunotherapy, according to a retrospective…
Meeting News

Liquid biopsies identify potential new treatment targets for advanced prostate cancer

February 14, 2017
A liquid biopsy test identified a number of genetic changes in cell-free circulating-tumor DNA of patients with advanced prostate cancer, according…
Meeting News

Benefits of immunotherapy for advanced kidney cancer may persist after therapy cessation

February 13, 2017
Patients with advanced kidney cancer who stop
In the Journals Plus

Direct-to-consumer genetic testing does not improve habits in high-risk adults

January 23, 2017
Most adults who received elevated direct-to-consumer personal genomic testing to detect risk for single nucleotide polymorphism–based cancer…
Cover Story

‘Silver tsunami’ requires ‘all-hands-on-deck’ approach to cancer survivorship

HemOnc Today, January 10, 2017
The number of cancer survivors in the United States is projected to swell from 15.5 million in 2016 to more than 26 million by 2040. By then, nearly…
In the Journals Plus

Targeted CAR T-cell therapy may be ‘game changer’ for glioblastoma

December 29, 2016
Chimeric antigen receptor T-cell therapy induced tumor regression in a patient with malignant glioblastoma, according to a brief report published in…

Lung cancer foundation honors City of Hope department chair

December 2, 2016
Ravi Salgia , MD, chair of the department of medical oncology and therapeutics research at City of Hope, received the Asclepius Award…

City of Hope announces faculty appointments

September 10, 2016
Several clinicians have joined the faculty at City of Hope. Flavia Pichiorri , PhD, has been appointed associate professor in…

$1 million gift establishes professorship in women’s cancers at City of Hope

August 25, 2016
A $1 million gift has established an endowed professorship in City of Hope’s women’s cancers program. Joanne Mortimer, MD,